REFERENCES 1. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect 2005;60:40–45. 2. Floret N, Bailly P, Bertrand X, et al. Results from a four‐year study on the prevalence of nosocomial infections in Franche‐Comte: attempt to rank the risk of nosocomial infection. J Hosp Infect 2006;63:393–398. 3. Humphreys H, Newcombe RG, Enstone J, et al. Four country healthcare associated infections prevalence survey 2006: risk factor analysis. J Hosp Infect 2008;69:249–257. 4. Kritsotakis EI, Dimitriadis I, Roumbelaki M, et al. Case‐mix adjustment approach to benchmarking prevalence rates of nosocomial infection in hospitals in Cyprus and Greece. Infect Control Hosp Epidemiol 2008;29: 685–692. 5. Lyytikäinen O, Kanerva M, Agthe N, Möttönen T, Ruutu P, Finnish Prevalence Survey Study Group. Healthcare‐associated infections in Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Infect 2008;69: 288–294. 6. Reilly J, Stewart S, Allardice G, et al. NHS Scotland national prevalence survey. Final report 2007. Glasgow: Health Protection Scotland; 2007. 7. Gordts B, Vrijens F, Peeters G, et al. Nationwide investigation into the prevalence of nosocomial infections in Belgium. Abstract at ECCMID 2009. 8. Defez C, Fabbro‐Peray P, Cazaban M, Boudemaghe T, Sotto A, Daurès JP. Additional direct medical costs of nosocomial infections: an estimation from a cohort of patients in a French university hospital. J Hosp Infect 2008;68: 130–136. 9. Fabbro‐Peray P, Sotto A, Defez C, et al. Mortality attributable to nosocomial infection: a cohort of patients with and without nosocomial infection in a French university hospital. Infect Control Hosp Epidemiol 2007;28: 265–272. 10. Goebbels ELPE. Prevention of surgical infections through surveillance. Dissertation, University of Utrecht; 2002. p. 101–116. 11. Hopmans TEM, Blok HEM, Troelstra A, Bonten MJM. Prevalence of hospital‐acquired infections during successive surveillance surveys conducted at a university hospital in the Netherlands. Infect Control Hosp Epidemiol 2007;28:459–465. 12. Erntell M, Skoog G, Cars O, et al. Changes in patterns of antimicrobial use in Swedish hospitals from 2003 to 2006 following the introduction of large‐scale nationwide point prevalence studies. Abstract at ECCMID 2008. 13. European Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe 2008. Stockholm: European Centre for Disease Prevention and Control; 2008. 14. French Prevalence Survey Study Group. Prevalence of nosocomial infections in France: results of the nationwide survey in 1996. J Hosp Infect 2000;46:186–193. 15. Smyth ETM, McIlvenny G, Enstone JE, et al. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect 2008;69:230–248. 16. Gastmeier P, Weitzel‐Kage D, Behnke M, Eckmanns T. Surveillance of Clostridium difcile‐associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD‐KISS). Int J Antimicrob Agents 2009;33: S19–S23. 17. Notermans DW, Kooi TII van der, Goorhuis A, Debast SB, Benthem BHB van, Kuijper EJ. Epidemiology of Clostridium difcile PCR ribotype 027 in the Netherlands 2005–present and the emergence of other subtypes. Nederl Tijdschr Geneesk 2008;152:1937–1940. 18. Gastmeier P, Kampf G, Wischnewski N, et al. Prevalence of nosocomial infections in representative 5 101 Prevalence of nosocomial infections: first four national studies
RkJQdWJsaXNoZXIy MTk4NDMw